A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Khan, S.; Siddique, R.; Bai, Q.; Shabana; Liu, Y.; Xue, M.; Nabi, G.; Liu, J. Coronaviruses Disease 2019 (COVID-19): Causative Agent, Mental Health Concerns, and Potential Management Options. J. Infect. Public Health 2020, 13, 1840–1844. [Google Scholar] [CrossRef]
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int (accessed on 13 November 2023).
- Abou Hassan, F.F.; Bou Hamdan, M.; Ali, F.; Melhem, N.M. Response to COVID-19 in Lebanon: Update, Challenges and Lessons Learned. Epidemiol. Infect. 2023, 151, e23. [Google Scholar] [CrossRef]
- Mumtaz, G.R.; El-Jardali, F.; Jabbour, M.; Harb, A.; Abu-Raddad, L.J.; Makhoul, M. Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out. Vaccines 2021, 9, 697. [Google Scholar] [CrossRef]
- Muangman, S.; Pimainog, Y.; Kunaratnpruk, S.; Kanchanaphum, P. The Prevalence of COVID-19 Infection in Students and Staff at a Private University in Thailand by Rapid SARS-CoV-2 Antigen Detection Assay. J. Environ. Public Health 2022, 2022, 2350522. [Google Scholar] [CrossRef]
- Domiati, S.; Hodeib, F.; El Majzoub, R.; Sacre, H. COVID-19 Vaccination Acceptability: A Cross-Sectional Study Among Lebanese Residents. Disaster Med. Public Health Prep. 2023, 17, e421. [Google Scholar] [CrossRef]
- Baroud, T.; Masri, J.E.; Shammaa, H.; Saleh, M.; Chanbour, H.; Salemeh, P. The Impact of COVID-19 Pandemic, Financial Wellness, and Online Teaching on Schoolteachers’ Mental Health: A Cross-Sectional Study in Lebanon. Int. J. Clin. Res. 2022, 3, 150–161. [Google Scholar] [CrossRef]
- Bizri, A.R.; Khachfe, H.H.; Fares, M.Y.; Musharrafieh, U. COVID-19 Pandemic: An Insult Over Injury for Lebanon. J. Community Health 2021, 46, 487–493. [Google Scholar] [CrossRef]
- Bou-Hamad, I.; Hoteit, R. Factors Motivating Lebanese Youth to Adopt COVID-19 Good Practices: A Cross-Sectional Study. Front. Public Health 2023, 11, 987187. [Google Scholar] [CrossRef]
- Nasser, Z.; Jamaleddine, Y.; Ismail, O.; Saab, A.; Daoud, R.; FARES, Y.; Abou-Abbas, L. Lebanese University Students and COVID-19: A Survey on Their Related-Knowledge, Practice, and Behaviors. J. Prev. Med. Hyg. 2022, 63, E213–E218. [Google Scholar] [CrossRef]
- World Health Organization. A Cross-Sectional Study of Knowledge, Attitude, Behaviour and Preventive Measures for COVID-19 Infection in Lebanon. Available online: http://www.emro.who.int/emhj-volume-29-2023/volume-29-issue-4/a-cross-sectional-study-of-knowledge-attitude-behaviour-and-preventive-measures-for-covid-19-infection-in-lebanon.html (accessed on 13 November 2023).
- El Othman, R.; Touma, E.; El Othman, R.; Haddad, C.; Hallit, R.; Obeid, S.; Salameh, P.; Hallit, S. COVID-19 Pandemic and Mental Health in Lebanon: A Cross-Sectional Study. Int. J. Psychiatry Clin. Pract. 2021, 25, 152–163. [Google Scholar] [CrossRef]
- Geagea, N. The Impact of COVID-19 on Mental Health and Quality of Life Amongst Lebanese Adults: Cross-Sectional Study. Available online: https://survey.aub.edu.lb/index.php/694741?lang=en (accessed on 13 November 2023).
- Younes, S.; Safwan, J.; Rahal, M.; Hammoudi, D.; Akiki, Z.; Akel, M. Effect of COVID-19 on Mental Health among the Young Population in Lebanon. L’Encephale 2022, 48, 371–382. [Google Scholar] [CrossRef] [PubMed]
- El Khoury-Malhame, M.; Rizk, R.; Joukayem, E.; Rechdan, A.; Sawma, T. The Psychological Impact of COVID-19 in a Socio-Politically Unstable Environment: Protective Effects of Sleep and Gratitude in Lebanese Adults. BMC Psychol. 2023, 11, 14. [Google Scholar] [CrossRef] [PubMed]
- Feghali, R.; Merhi, G.; Kwasiborski, A.; Hourdel, V.; Ghosn, N.; Tokajian, S. Genomic Characterization and Phylogenetic Analysis of the First SARS-CoV-2 Variants Introduced in Lebanon. PeerJ 2021, 9, e11015. [Google Scholar] [CrossRef] [PubMed]
- Merhi, G.; Trotter, A.J.; de Oliveira Martins, L.; Koweyes, J.; Le-Viet, T.; Abou Naja, H.; Al Buaini, M.; Prosolek, S.J.; Alikhan, N.-F.; Lott, M.; et al. Replacement of the Alpha Variant of SARS-CoV-2 by the Delta Variant in Lebanon between April and June 2021. Microb. Genom. 2022, 8, mgen000838. [Google Scholar] [CrossRef] [PubMed]
- Nour, D.; Rafei, R.; Lamarca, A.P.; de Almeida, L.G.P.; Osman, M.; Ismail, M.B.; Mallat, H.; Berry, A.; Burfin, G.; Semanas, Q.; et al. The Role of Lebanon in the COVID-19 Butterfly Effect: The B.1.398 Example. Viruses 2022, 14, 1640. [Google Scholar] [CrossRef]
- Hoballah, A.; El Haidari, R.; Siblany, G.; Abdel Sater, F.; Mansour, S.; Hassan, H.; Abou-Abbas, L. SARS-CoV-2 Antibody Seroprevalence in Lebanon: Findings from the First Nationwide Serosurvey. BMC Infect. Dis. 2022, 22, 42. [Google Scholar] [CrossRef]
- Nour, D.; Ismail, M.B.; Osman, M.; Rafei, R.; Kasir, D.; Dabboussi, F.; Colson, P.; Hamze, M. Evaluation of SARS-CoV-2 Anti-Spike Antibody Levels and Breakthrough Infection Risk among Vaccinated Adults in North Lebanon. PLoS ONE 2024, 19, e0302579. [Google Scholar] [CrossRef]
- World Health Organization. COVID-19 Cases|WHO COVID-19 Dashboard. Available online: https://data.who.int/dashboards/covid19/cases (accessed on 3 March 2024).
- Rayan, R.A. Seasonal Variation and COVID-19 Infection Pattern: A Gap from Evidence to Reality. Curr. Opin. Environ. Sci. Health 2021, 20, 100238. [Google Scholar] [CrossRef]
- Carabelli, A.M.; Peacock, T.P.; Thorne, L.G.; Harvey, W.T.; Hughes, J.; de Silva, T.I.; Peacock, S.J.; Barclay, W.S.; de Silva, T.I.; Towers, G.J.; et al. SARS-CoV-2 Variant Biology: Immune Escape, Transmission and Fitness. Nat. Rev. Microbiol. 2023, 21, 162–177. [Google Scholar] [CrossRef]
- Notarte, K.I.; Guerrero-Arguero, I.; Velasco, J.V.; Ver, A.T.; Santos de Oliveira, M.H.; Catahay, J.A.; Khan, M.S.R.; Pastrana, A.; Juszczyk, G.; Torrelles, J.B.; et al. Characterization of the Significant Decline in Humoral Immune Response Six Months Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review. J. Med. Virol. 2022, 94, 2939–2961. [Google Scholar] [CrossRef]
- Hansen, C.H.; Michlmayr, D.; Gubbels, S.M.; Mølbak, K.; Ethelberg, S. Assessment of Protection against Reinfection with SARS-CoV-2 among 4 Million PCR-Tested Individuals in Denmark in 2020: A Population-Level Observational Study. Lancet 2021, 397, 1204–1212. [Google Scholar] [CrossRef] [PubMed]
- Peng, J.; Su, D.; Zhang, Z.; Wang, M. Identification and Management of Asymptomatic Carriers of Coronavirus Disease 2019 (COVID-19) in China. Influenza Other Respir. Viruses 2020, 14, 599–600. [Google Scholar] [CrossRef] [PubMed]
- Oran, D.P.; Topol, E.J. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann. Intern. Med. 2020, 173, 362–367. [Google Scholar] [CrossRef] [PubMed]
- Allen, J.; Toapanta, F.R.; Chen, W.; Tennant, S.M. Understanding Immunosenescence and Its Impact on Vaccination of Older Adults. Vaccine 2020, 38, 8264–8272. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Coronavirus. Available online: https://www.who.int/health-topics/coronavirus (accessed on 19 August 2024).
- National Health and Medical Research Council. Severity of COVID-19 Illness in Children and Young Adults. Available online: https://www.nhmrc.gov.au/sites/default/files/2023-02/NCHRAC-Advice-20-Severity-of-COVID-in-children.pdf (accessed on 1 October 2024).
- Dzinamarira, T.; Nkambule, S.J.; Hlongwa, M.; Mhango, M.; Iradukunda, P.G.; Chitungo, I.; Dzobo, M.; Mapingure, M.P.; Chingombe, I.; Mashora, M.; et al. Risk Factors for COVID-19 Infection among Healthcare Workers. A First Report from a Living Systematic Review and Meta-Analysis. Saf. Health Work 2022, 13, 263–268. [Google Scholar] [CrossRef] [PubMed]
- Helou, M.; Zoghbi, S.; El Osta, N.; Mina, J.; Mokhbat, J.; Husni, R. COVID-19 Infection and Seroconversion Rates in Healthcare Workers in Lebanon: An Observational Study. Medicine 2023, 102, e32992. [Google Scholar] [CrossRef]
- Chakraborty, C.; Bhattacharya, M.; Chopra, H.; Islam, M.A.; Saikumar, G.; Dhama, K. The SARS-CoV-2 Omicron Recombinant Subvariants XBB, XBB.1, and XBB.1.5 Are Expanding Rapidly with Unique Mutations, Antibody Evasion, and Immune Escape Properties—An Alarming Global Threat of a Surge in COVID-19 Cases Again? Int. J. Surg. Lond. Engl. 2023, 109, 1041–1043. [Google Scholar] [CrossRef]
- Tamura, T.; Irie, T.; Deguchi, S.; Yajima, H.; Tsuda, M.; Nasser, H.; Mizuma, K.; Plianchaisuk, A.; Suzuki, S.; Uriu, K.; et al. Virological Characteristics of the SARS-CoV-2 Omicron XBB.1.5 Variant. Nat. Commun. 2024, 15, 1176. [Google Scholar] [CrossRef]
Characteristic | Total (N = 357) | |
---|---|---|
N | % | |
Sex | ||
Female | 243 | 68.07 |
Male | 114 | 31.93 |
Age-groups | ||
18–23 years | 346 | 96.92 |
24–30 years | 11 | 3.08 |
Marital status | ||
Single | 347 | 97.2 |
Married | 8 | 2.24 |
Divorced | 2 | 0.56 |
Nationality | ||
Lebanese | 351 | 98.32 |
Syrian | 5 | 1.4 |
Palestinian | 1 | 0.28 |
District of residence | ||
Tripoli | 164 | 45.94 |
Akkar | 70 | 19.61 |
Menieh-Denieh | 56 | 15.69 |
Koura | 30 | 8.4 |
Zgharta | 20 | 5.6 |
Batroun | 8 | 2.24 |
Jbeil | 4 | 1.12 |
Bcharri | 3 | 0.84 |
Bekaa | 1 | 0.28 |
Kesrwan | 1 | 0.28 |
Blood group | ||
A | 172 | 48.18 |
B | 47 | 13.17 |
AB | 18 | 5.04 |
O | 120 | 33.61 |
Smoking status | ||
Never smokers | 336 | 94.12 |
Ex-smokers | 1 | 0.28 |
Current smokers | 20 | 5.6 |
Health condition ! | ||
Yes | 24 | 6.72 |
No | 333 | 93.28 |
Current respiratory infections | ||
Present | 31 | 8.68 |
Absent | 326 | 91.32 |
Past SARS-CoV-2-infection status | ||
Yes | 143 | 40.06 |
Symptomatic | 98 | 68.53 * |
Hospitalization | 4 | 4.08 ** |
Long term symptoms | 26 | 26.53 ** |
No | 214 | 59.94 |
Coronavirus vaccine status | ||
Yes | 208 | 58.26 |
Pfizer | 183 | 88 *** |
AstraZeneca | 4 | 1.92 *** |
Pfizer + AstraZeneca | 2 | 0.96 *** |
NA | 19 | 9.12 *** |
No | 149 | 41.74 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rafei, R.; Tajer, L.; Nour, D.; Abboud, K.; Ankoud, D.; Osman, M.; Bedotto, M.; Ismail, M.B.; Dabboussi, F.; Colson, P.; et al. A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon. Pathogens 2024, 13, 872. https://doi.org/10.3390/pathogens13100872
Rafei R, Tajer L, Nour D, Abboud K, Ankoud D, Osman M, Bedotto M, Ismail MB, Dabboussi F, Colson P, et al. A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon. Pathogens. 2024; 13(10):872. https://doi.org/10.3390/pathogens13100872
Chicago/Turabian StyleRafei, Rayane, Layla Tajer, Dalal Nour, Karen Abboud, Dima Ankoud, Marwan Osman, Marielle Bedotto, Mohamad Bachar Ismail, Fouad Dabboussi, Philippe Colson, and et al. 2024. "A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon" Pathogens 13, no. 10: 872. https://doi.org/10.3390/pathogens13100872
APA StyleRafei, R., Tajer, L., Nour, D., Abboud, K., Ankoud, D., Osman, M., Bedotto, M., Ismail, M. B., Dabboussi, F., Colson, P., & Hamze, M. (2024). A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon. Pathogens, 13(10), 872. https://doi.org/10.3390/pathogens13100872